Top Institutions in Infectious Diseases and Post-Infectious Sequelae
Institutions leading in this area typically conduct longitudinal cohort studies, clinical trials, and epidemiological surveillance of emerging infectious diseases, with expertise in viral pathogenesis, dermatology, infectious disease sequelae, and psychosocial outcomes. They often collaborate with public health agencies and utilize multidisciplinary approaches to understand and manage post-viral complications.
-
#1
Centers for Disease Control and Prevention (CDC)
Atlanta, GA
As the leading U.S. public health agency, CDC spearheads surveillance, research, and response efforts for emerging infectious diseases including mpox, and leads large cohort studies like the Life After Mpox (LAMP) study to characterize long-term sequelae.
Key Differentiators
- Infectious Diseases
- Epidemiology
- Public Health
-
#2
New York University Grossman School of Medicine
New York, NY
NYU Grossman has been actively involved in clinical research on mpox, including patient recruitment and follow-up in urban clinics, contributing to understanding of dermatologic and psychosocial sequelae in diverse populations.
Key Differentiators
- Infectious Diseases
- Dermatology
- Sexual Health
-
#3
University of Texas Health Science Center at Houston (UTHealth)
Houston, TX
UTHealth has contributed to mpox research through clinical cohort studies and has expertise in managing functional sequelae such as anorectal and urinary symptoms post-infection, integrating infectious disease and urologic care.
Key Differentiators
- Infectious Diseases
- Urology
- Epidemiology
-
#4
Johns Hopkins University School of Medicine
Baltimore, MD
Johns Hopkins is renowned for its research in infectious diseases and post-infectious neuropsychiatric and psychosocial outcomes, contributing to understanding mental health sequelae following viral infections including mpox.
Key Differentiators
- Infectious Diseases
- Dermatology
- Psychiatry
-
#5
Massachusetts General Hospital (MGH) / Harvard Medical School
Boston, MA
MGH and Harvard Medical School have extensive expertise in emerging infectious diseases and dermatologic manifestations, conducting clinical research and providing advanced care for patients with mpox and its sequelae.
Key Differentiators
- Infectious Diseases
- Dermatology
- Public Health
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
